It is increasingly recognized that the high prevalence of obstructive sleep apnoea (OSA), and its associated cardio-metabolic morbidities make OSA a burden for society. Continuous positive airway pressure (CPAP), the gold standard treatment, needs to be used for more than 4 h/night to be effective, but suffers from relatively poor adherence. Furthermore, CPAP is likely to be more effective if combined with lifestyle changes. Thus, the remote telemonitoring (TM) of OSA patients in terms of CPAP use, signalling of device problems, following disease progression, detection of acute events and monitoring of daily physical activity is an attractive option. In the present review, we aim to summarize the recent scientific data on remote TM of OSA patients, and whether it meets expectations. We also look at how patient education and follow-up via telemedicine is used to improve adherence and we discuss the influence of the profile of the healthcare provider. Then, we consider how TM might be extended to encompass the patient's cardio-metabolic health in general. Lastly, we explore how TM and the deluge of data it potentially generates could be combined with electronic health records in providing personalized care and multi-disease management to OSA patients.
INTRODUCTION
Obstructive sleep apnoea (OSA) is a major worldwide health concern, particularly as its social and multiorgan consequences make it an economic burden for society. 1 It is estimated that OSA afflicts nearly 30 million adults in the U.S. and in 2015 the cost of diagnosing and treating this condition was approximately $US 12.4 billion. 2 Approximately 50% of these costs have been attributed to provide continuous positive airway pressure (CPAP) treatment and oral appliances, although a significant proportion of the costs was assigned to follow-up visits and home-care providers' services. In the U.S., in 2011 alone, Medicare received more than 1 million polysomnogram (PSG) claims and reimbursed $US 565 million for PSG. Over 6 years from 2005 to 2011, Medicare payments for PSG increased by 39%. 3 Considering the advent of emerging monitoring technologies and the introduction of wireless connectivity into patients' homes, the potential for remote telemonitoring (TM) to change and restructure current care management paradigms is immense.
OSA is associated with obesity in more than 60% of patients and with co-morbidities including hypertension, arrhythmias, stroke, coronary heart disease and metabolic dysfunction. 4, 5 The co-morbidities are of major importance because they have a significant impact on healthcare use 6 and on mortality in patients with OSA. 7 Consequently, contemporary OSA management must target not only increasing adherence to CPAP treatment 8 but should also include educational and interventional strategies aimed at improving healthy everyday habits with precise goals, promoting weight control and increasing physical activity.
Remote home monitoring of CPAP devices is being developed 9, 10 with the potential of reducing the volume of clinic visits, assisting home-care providers workload in between physicians visits, and providing early detection of patients' problems. 11 Devices that generate outcome data will also support the integrated care of comorbidities and self-management of sleep apnoea.
In the present review, we aim to summarize the recent scientific data on remote TM of OSA patients. We will outline the potential clinical applications and consider the possible barriers to widespread adoption. Finally, we will discuss how CPAP TM could generate 'big data' to support patient-centred care and patientoriented outcome studies. 13, 14 Search strategy and selection criteria for literature included in the review
We searched PubMed for publications between 1 January 2010 and 30 March 2017, that related to remote monitoring in OSA patients, published in English. We used the search terms 'remote monitoring', 'telemonitoring', 'CPAP', 'telemedicine', 'integrated care', 'sleep apnoea', 'sleep', and 'sleep disordered breathing'. Selection for inclusion was based on our expertise and our perception of the study's relevance and effect on the field. We also cite older articles to provide background information and context.
TM ADHERENCE AND PROGRESS OF CPAP-TREATED OSA SYNDROME PATIENTS Telemedicine and sleep apnoea
Remote monitoring and care delivery to patients with OSA who are receiving CPAP therapy needs to be discussed in terms of the concept of telemedicine. The term telemedicine was coined in the 1970s and means 'healing at distance', nowadays signifying the use of Information Communication Technology to improve patient care, increase access to health care services and to medical records. 15 As there was no single definite definition for telemedicine the World Health Organization (WHO) adopted an inclusive definition 'The delivery of health care services, where distance is a critical factor, by all health care professionals using information and communication technologies for the exchange of valid information for diagnosis, treatment and prevention of disease and injuries, research and evaluation and for the continuing education of health care providers, all in the interests of advancing the health of individuals and their communities'. 16 Currently, there is a significant shortage of boardcertified sleep specialists in the U.S., and the gap is going to widen gradually due to a shortfall of over 46 000 specialists, because of an undersupply of residency graduates. 17 Telemedicine can be utilized in these situations to provide sleep specialist care to patients in underserved areas. Telemedicine with telehealth applications can provide more efficient, costeffective and accessible pathways to expand health care services beyond traditional office settings. In some ways, one could state that the sleep medicine field was early to embrace telemedicine practice by using telehealth applications and remote monitoring technologies to monitor CPAP adherence and to diagnose OSA by home sleep testing. 18 Use of wireless modem technology has made it possible to integrate a telemedicine approach in monitoring adherence to CPAP therapy and to manage sleep apnoea patients remotely. The efficacy of wireless TM on CPAP effectiveness and compliance was evaluated in the early stages of sleep telemedicine in 2007. In this pilot study, 45 patients were randomized to either standard care or telemonitored clinical care and they were followed for 2 months. Study findings revealed that TM of CPAP adherence and use of data by the clinical team to address adherence was as effective as usual care without TM. In this study, patients assigned to wireless TM used CPAP an average of 4.1 AE 1.8 h/night and 78 AE 22% of the nights. Patients assigned to the standard care group used CPAP an average 2.8 AE 2.2 h/night and 60 AE 32% of the nights, but the difference in CPAP usage between these two groups did not reach statistical significance. 19 In a randomized clinical trial, Stepnowsky et al. utilized an interactive website tailored for OSA patients to evaluate the effect of such an intervention on CPAP adherence. 20 Internet intervention in the treatment group was based around wireless TM of CPAP data. Utilization of the interactive website provided both patient and provider access to monitoring of treatment efficacy and adherence, to troubleshoot CPAP use related problems and for patients to express preferences and needs. In this study, the TM group's average CPAP use was 1 h/night greater than the standard treatment group at 2 months and at 4 months. 20 In a prospective, non-blinded, multi-centre study involving 122 patients with OSA, effectiveness and coaching costs were evaluated using U-Sleep, a webbased automated telehealth program. 21 In this study, the telehealth group received emails and/or text messages. In the standard care arm, follow-up consisted of scheduled phone calls on days 1, 7, 14 and 30. Results of this study revealed that there was no statistically significant difference in Medicare adherence, daily CPAP usage, CPAP efficacy or change in Epworth Sleepiness Scale scores between telehealth and standard care groups, but the trend favoured the telehealth group. The coaching time required was significantly lower in the telehealth group. 21 A follow-up study (Tele-OSA) was performed by Chang and colleagues at Kaiser Permanente evaluating the impact of U-Sleep on CPAP adherence. 22 This study further evaluated the effect of remote telemedicine education delivered as an automated interactive webbased platform (Emmi Solutions, Inc., Chicago, IL, USA). Patients (1455) were randomized into four trial arms: (i) usual care; (ii) usual care + education; (iii) usual care + U-Sleep; and (iv) usual care + education + U-Sleep. U-Sleep demonstrated statistically significant improvement in the rate of achieving Medicare adherence at 3 months (65.6-73.2% in the two U-Sleep arms vs 53.5-61% in the two non-U-Sleep arms). Telemedicine education did not demonstrate a statistically significant impact on CPAP adherence, but it did result in a relative improvement in attendance rates by about 10% (P = 0.02). Unfortunately, post hoc analysis of study patients indicated that the U-Sleep effect diminished 3 months after the patient feedback system was 'turned off' with a gradual decline in CPAP adherence until it was identical to the non-U-Sleep patients ( Fig. 1) . Interestingly, a sub-group of U-Sleep patients arbitrarily had the messaging continued indefinitely and the higher degree of CPAP usage persisted to 1 year (% days used at 330-360 days was 58.4 AE 41.1 vs 48.1 AE 43.9%, P = 0.05). This study suggests that this automated TM strategy needs to be continued indefinitely for sustained effect. In another web-based positive airway pressure (PAP) adherence monitoring study, Kuna et al. evaluated the effect of web-based access to PAP usage over a period of 3 months with and without a financial incentive in the first week after CPAP treatment. 23 In this study, 138 patients were randomized to usual care, usual care with access to web-based PAP usage and usual care with access to web-based PAP usage with a financial incentive. PAP adherence was significantly higher in patients with web-based access to PAP usage. Average PAP use was 4.7 AE 3.3 h in the usual care group and 5.9 AE 2.5 and 6.3 AE 2.5 h in the web-based access to PAP usage groups with and without financial incentive. Functional Outcomes of Sleep Questionnaire (FOSQ) scores at 3 months improved with statistical significance in all three groups, but the change in FOSQ scores of webbased access to PAP usage groups were not different from the control group. 23 Fox et al. conducted a singlecentre, non-blinded and randomized controlled trial in 75 adults with moderate to severe OSA to study the impact of TM in improving PAP adherence. 24 In the TM group, research coordinators closely followed PAP adherence, mask leaks, residual apnoea-hypopnoea index and 90th percentile pressure that was greater than 16 cm H 2 O. The research coordinator contacted participants in the TM group to discuss symptoms such as dry mouth, discomfort or mask leak. If nonadherence was because of such symptoms, the patient was referred to a PAP coordinator to troubleshoot PAPrelated problems such as prescribing a different mask, using a chin strap, adjusting pressure or humidity settings or prescribing saline nasal sprays. Remaining follow-up and monitoring was almost similar in both telemedicine and standard groups. After a 3-month follow-up, mean PAP adherence was higher in the TM group compared to standard group (321 min/day vs 207 min/day). 24 Sparrow et al. used telephone linked communication (TLC), an automated telephone-based and low-cost alternative intervention to find the impact of telecommunication in improving adherence to CPAP therapy. 25 TLC-CPAP monitors patients' CPAP-related symptoms and self-reported adherence, and provides structured feedback to promote CPAP adherence. In this clinical trial 250 patients with OSA, already started on PAP therapy, were randomized to the TLC-CPAP treatment group or a placebo control group. The median observed CPAP use was 1 h/night higher in the FOSQ-CPAP group at 6-month follow-up and 2 h/night higher at 1 year follow-up. 25 Who delivers the intervention by remote TM or telemedicine is worth discussion. Whether the support for PAP adherence promotion is provided by a boardcertified physician or primary care physician is much debated in the U.S. considering the fact that the referrals exceed the capacity of sleep centres. In a national survey of 666 participants in the U.S., accreditation of sleep centres and/or certification status of physicians was associated with better indexes of clinical management in patients with OSA. 26 To follow on from this a prospective pragmatic multi-centre comparative study was performed involving 502 patients in four sleep centres in the U.S. This showed a similar association between the accreditation-certification status of sleep centres and physicians and better PAP adherence, better patient education, better patient satisfaction and greater timeliness. 27 Specifically, better patient education that fostered risk perception may have been partly responsible for the observed association. Nevertheless, in a randomized controlled trial of patients with OSA performed by Chai-Coetzer and colleagues where they compared a primary care model supported by nurses with significant expertise in managing patients with OSA to a sleep specialist model they found the two treatment approaches to be comparable. 28 In contrast, Pamidi et al. used wireless modem technology to download CPAP adherence data to find the impact of a sleep specialist consultation before a diagnostic PSG. In this study, mean daily CPAP usage was 58 min higher in the sleep specialist consultation group compared to the non-sleep specialist group. 29 Better organization of care between primary care and sleep specialists with sharing of workload and expertise is being advocated as a form of 'task-shifting' of some of the simpler patients to primary care physicians in order to improve access of patients with complex problems to sleep specialists. However, both the scientific evidence and a willingness to collaborate are needed between these and other stakeholders in order to move such an agenda forward.
Gauging the effect of telemedicine on process outcomes (such as timeliness and access to care) in addition to client outcomes (such as CPAP adherence and patient satisfaction) after accounting for other patient-and provider-based variables that influence CPAP adherence and downstream outcomes would be important. However, in a study conducted by Parikh and colleagues that compared telemedicine via videoconference versus in- person follow-up at a sleep centre on patient satisfaction and adherence, there was no significant difference in the patient satisfaction score and CPAP adherence. 30 Based upon evidence from the above-mentioned literature, even though remote monitoring of OSA and integration of telemedicine into sleep medicine is in its early stages, outcomes seem to favour telemedicine approaches. In future, large-scale adequately powered pragmatic clinical trials are needed to better understand the effectiveness and the role of the telemedicine approach in managing sleep medicine disorders.
Remote monitoring of Positive Airway
1 However, the impact of CPAP on functional and cardiovascular outcomes is inadequate below 4 h/ night of CPAP usage. The overall effect of CPAP on blood pressure (BP) in an unselected OSA population was minor with an effect size close to −2 mm Hg for 24 h mean BP. This BP reduction is correlated with the nightly duration of CPAP use with a 1-h-per-night increase in CPAP use being associated with an additional reduction in systolic BP of 1.5 mm Hg. 31 The prevalence of residual excessive sleepiness is significantly lower in individuals using CPAP more than 6 h/ night compared with those who use the device less than 4 h/night (8.7% vs 18.5%). 32 Improving CPAP adherence thus remains a major clinical challenge, because inadequate use of CPAP compromises clinical outcomes and puts patients at risk for cardiovascular disease.
Wireless TM of CPAP treatment uses digital technologies to collect health data in the patient's home, and electronically transmits the information on applied pressures, air leaks, residual events under CPAP and objective adherence to health care providers. 9, 10, 33, 34 This kind of remote CPAP TM is now available in many countries but only limited data are available regarding its influence on CPAP adherence. A first pilot study in 45 patients showed a trend toward increasing CPAP usage (4.1 AE 1.8 vs 2.8 AE 2.2, P < 0.07, in the TM and the control group, respectively). 19 This proof of concept randomized controlled trial was certainly underpowered to reach significance but provided a rationale for conducting larger clinical and cost-effectiveness trials. Five studies in the field are currently available involving a total of close to five hundred OSA patients ( Table 1 ). The impact of TM on CPAP adherence was highly dependent on the pre-existing organization of standard care in the control arm. The study by Fox et al. 24 is the only one in which TM resulted in improved CPAP adherence. However, in this study, CPAP adherence in the usual care group was quite low with a median value of 105 min/day of CPAP usage.
One of the capabilities of TM is probably the early detection of problems (such as leaks or persistent respiratory events of sleep apnoea) thus facilitating appropriate interventions, and thereby improving the patient's early experience with CPAP. Available studies did not report significant differences in terms of functional outcomes (sleepiness, health-related quality of life) nor side effects when comparing TM with usual care. The virtue of TM is that it enables coaching to be adapted to the patient's needs. Accordingly, the majority of the studies (Table 1) demonstrated that TM may save health care resources 34 without compromising the short-or long-term effectiveness of CPAP treatment.
Patients' perspectives
According to a recent European study, patients did not raise privacy issues with TM and were not concerned that their CPAP data were being monitored. 35 However, they expect to have to spend less time at the hospital or for travelling, with reductions in costs for fuel and parking. 36 Patients also anticipate that consultants will be more flexible in giving them appointments when the TM system identifies problems in CPAP treatment progress. What is unclear is whether patients expect their physicians to be routinely monitoring their data on a regular basis. However, such expectations cannot be met without having intermediary providers (such as respiratory therapists in the USA and home-care providers in Europe) to assign certain trigger thresholds for the PAP adherence data to trigger when adherence is not being met. Social and emotional responses to remote monitoring, as well as whether patients live in urban or rural areas, and their country or continent, certainly influence the perception of remote monitoring for the integrated care of chronic diseases.
Monitoring disease progression and detection of acute events
Practice of CPAP follow-up is inconsistent across countries and sleep centres, with CPAP follow-up appointments varying from 3 months to yearly according to physician preferences and availability of resources. In Europe, no check-ups occur between follow-up visits as automatic remote monitoring with predefined alerts now allows constant surveillance with the ability to identify salient problems rapidly. Figure 2 depicts a demonstrative example of acute cardiac decompensation associated with emergent central sleep apnoea untreated by the CPAP device that had been initiated for classical OSA. Conversely, in the U.S. patients with certain insurance payers (such as Medicare) require a mandatory face-to-face follow-up visit between 60 and 90 days following CPAP set-up in order to ensure adherence, and furthermore annual visits to confirm PAP adherence before CPAP-related supplies can be issued. The requirement for a similar face-to-face visit within 6 months of the diagnostic sleep study that established the diagnosis of OSA in the first place along with the mandatory follow-up visits undermine the concept of telemedicine in such individuals. Although some Medicare beneficiaries in underserved areas and other insurers do not require such a face-to-face visit, differences across payers imposes workflow complexities that destabilize telemedicine implementation efforts.
Physicians' perspectives
Although an argument can be made that physicians need to be allocated some time each day, within their busy work schedules, to consult patient data at the backend and react to alarms if necessary; the current model of care delivery and workload burden render this infeasible in the USA, although other practice settings outside of the USA may allow such a model of care delivery.
INTEGRATED CARE OF OSA AND RELATED CO-MORBIDITIES VIA TM/TELEMEDICINE
About half of OSA patients are minimally symptomatic but present various combinations of comorbidities and environmental risk factors. 4 The prognosis of their OSA is mainly related to these co-morbidities 7 and vice versa OSA is now accepted as a modulator of the course and prognosis of many chronic diseases including hypertension, diabetes and cardiac failure. 37 In OSA subgroups with clusters of co-morbidities, CPAP indication mainly aims to reduce cardio-metabolic risk. However, CPAP treatment alone has a limited impact on biomarkers of cardiovascular risk, prevention of late cardiovascular events and excess mortality. 38, 39 CPAP must be combined with other therapies including weight loss and physical activity 40 to achieve overall risk reduction. 41 Consequently, TM of CPAP treatment is now proposed as one component of more complex and integrated strategies that use mobile health applications and wearable sensors to monitor physiological variables such as blood pressure, weight, sleep duration and number of steps per day. Data fusion and integration with electronic health records promises comprehensive and personalized care for OSA patients. 10 Beyond monitoring activities, webeducation and/or coaching in addition to CPAP TM are associated with a gradual increase in CPAP adherence. 10 Regarding co-morbidities, CPAP treatment supported by a telemedicine system that included monitoring of blood pressure and sent reminders for healthy diet and physical activity via smartphones did not demonstrate efficacy in reducing cardiovascular risk in OSA patients when used as secondary prevention. 12 This study emphasizes the need for supervised and personalized diet and tailored physical activity training programs, in addition to CPAP, when aiming at decreasing cardio-metabolic risk factors. A more face-to-face persuasive strategy may be needed through daily video chats (Skype) with a coach. These programs could also be supported by 'telehealth' as has been previously introduced for home telerehabilitation of COPD patients. 42, 43 Effective monitoring of millions of OSA patients requires rebuilding clinical care pathways (Fig. 3) . The first step is to determine the distinct phenotype of each patient 4, 44 allowing better anticipation of barriers to CPAP adherence and facilitating management of comorbidities across specialties. Ideally, the system should include an electronic medical record and, depending on the context and co-morbidities of a given patient, a number of wearable sensors and coaching sessions (Fig. 3) . 10 Although individual diseases still dominate healthcare delivery, research and education, the prevalence of individuals with multi-morbid chronic diseases (those with two or more chronic morbidities) is over 50% in middle-aged and elderly subjects. Each chronic disease specialty has developed its Figure 2 Acute decompensated heart failure detected by long-term telemonitoring of an OSA patient after several years of efficient CPAP treatment of OSA, a progressive increase in the residual AHI occurred mainly due to central events and preceded hospitalization for acute heart failure. , apnoea index; , apnoea-hypopnoea index, CPAP, continuous positive airway pressure; OSA, obstructive sleep apnoea.
own specific TM and health platforms. A major challenge for the future is to combine platforms for the integrated care of co-morbidities. An opening for such multi-disease management would be to tap the capability of pacemakers for diagnosis and monitoring of sleep apnoea. Among the deleterious consequences of sleep apnoea, the most alarming are arrhythmias and sudden cardiac death. Diagnosis of sleep apnoea using simple tools might reinforce the efficacy of cardiac implants in the prevention/treatment of cardiac arrhythmias. 45, 46 Advanced algorithms for the autoscoring of transthoracic impedance that can be built into pacemakers have been validated as a reliable method to identify sleep and might improve the management of patients with cardiac implants (Fig. 4) . 47 LEVERAGING 'BIG DATA' FROM CPAP TM 1 3 , 1 4 E-health and connected devices provide unprecedented opportunities for integrating co-management approaches, multi-actor interactions and patients' self-management. 48, 49 The rapid accumulation of digital health data (electronic hospital records, laboratory results, imaging, community care, connected devices, home monitoring platforms, etc.) represent a largely untapped source of knowledge for better detection, diagnosis and personalized follow-up of OSA patients. TM of CPAP devices has the potential to generate a data deluge that could be addressed by advanced analytics to generate new hypotheses and enhance personalized disease management. Using a data set from more than 100 000 patients we have distinguished several central sleep apnoea trajectories during CPAP therapy, and identified several different clinical phenotypes. The detection of treatmentemergent central sleep apnoea by TM could facilitate early intervention to reduce the risk of therapy discontinuation and justify the shift to more efficient ventilator modalities such as adapted servo-ventilation. 50 CPAP data remote monitoring and associated big data analyses provide opportunities to improve the care of OSA patients and boost clinical research. However, issues relating to privacy and security, especially for research purposes, imply rigorous controls on how the data are used and by whom. 51 Governments, academic organizations and private companies should work together to better delineate the rules. 52 The future success of OSA management will be strongly dependent upon expanding the collection of 'big data' from sources beyond CPAP metrics. Through implementation of health information technology systems that will: (i) connect both prescribed and consumer-based end-user technologies (including wearable sensors) to provider-based systems (electronic health records and middleware systems with advanced analytic functions); (ii) integrate end-to-end care to improve risk identification with automated facilitation of subsequent care delivery steps; (iii) improve patient-provider interchange including electronic messaging and survey instruments; (iv) integrate comprehensive clinical data from electronic health record; (v) include team-based care leveraging support providers to function within innovative workflows as a corresponding evolution to technology advancements; and (vi) integrate interdisciplinary care with an emphasis on impacting advanced clinical outcomes and expanding beyond a focus on therapy adherence. This expanded data collection that includes clinical, psychological, behavioural and patientreported information is powerful only if specific strategies and mechanisms are applied that make the data actionable. Sleep medicine can look forward to a future in which big data will enable effective population health management, increase automated care delivery mechanisms, advance patient self-care capabilities, provide predictive analytics for provider clinical decision support, present peer-to-peer support opportunities and enable the effectiveness of continuous realtime patient monitoring. The evolution of sleep medicine care is full of incredible opportunities given its natural reliance of technology and relevance to so many medical specialties. The field has the potential to be a model to the greater healthcare community in transforming the cost-effective management of chronic disease conditions. Figure 4 Autoscoring of transthoracic impedance measurements given by pacemakers allows the diagnosis of sleep apnoea. Note that the occurrence of severe sleep apnoea in this patient was associated with prominent nocturnal atrioventricular blocks. AF, atrial fibrillation; AVB, atrioventricular block; OSA, obstructive sleep apnoea; PM, pacemaker; RDI, respiratory disturbance index.
CONCLUSIONS
Remote monitoring of CPAP data allows disease progression to be followed and the detection of acute events. This can provide reassurance for the patient and reduce the number of CPAP follow-up visits. Improvement in adherence to treatment when CPAP use is telemonitored needs to be confirmed in more highly powered studies. To be effective the 'connectivity' probably needs to include more comprehensive health monitoring and lifestyle coaching.
